Furafylline
CAS No. 80288-49-9
Furafylline ( —— )
Catalog No. M20761 CAS No. 80288-49-9
Furafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 267 | In Stock |
|
10MG | 417 | In Stock |
|
25MG | 689 | In Stock |
|
50MG | 963 | In Stock |
|
100MG | 1305 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFurafylline
-
NoteResearch use only not for human use.
-
Brief DescriptionFurafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)
-
DescriptionFurafylline is a selective inhibitor of human cytochrome P450 (CYP)1A2 (IC50 : 0.07 μM)
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetP450
-
RecptorCYP450
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number80288-49-9
-
Formula Weight260.25
-
Molecular FormulaC12H12N4O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:12.5 mg/mL (48.03 mM)
-
SMILESCc1nc2n(Cc3ccco3)c(=O)n(C)c(=O)c2[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sesardic D Boobis A R Murray B P et al. Furafylline is a potent and selective inhibitor of cytochrome P450IA2 in man.[J]. British Journal of Clinical Pharmacology 1990 29(6):651-663.
molnova catalog
related products
-
Ginsenoside F1
Ginsenoside F1,an enzymatically modified derivative of ginsenoside Rg1, protection from ultraviolet-B-induced apoptosis is tightly correlated with ginsenoside-F1-mediated inhibition of ultraviolet-B-induced downregulation of Bcl-2 and Brn-3a expression.
-
(R)-Etomoxir sodium ...
(R)-Etomoxir sodium salt is R-form of Etomoxir. Etomoxir is a potent inhibitor of carnitine palmitoyltransferase-I (CPT-1).
-
Ellagic Acid Dihydra...
Ellagic Acid Dihydrate inhibit the CYP1A1-dependent activation of benzo[a]pyrene.